XR Naltrexone, Sublingual BUP-NX Deemed Equally Effective

Share this content:
XR Naltrexone, Sublingual BUP-NX Deemed Equally Effective
XR Naltrexone, Sublingual BUP-NX Deemed Equally Effective

WEDNESDAY, Nov. 15, 2017 (HealthDay News) -- Although initiation of extended-release naltrexone (XR-NTX) may be more difficult, XR-NTX and sublingual buprenorphine-naloxone (BUP-NX) are equally safe and effective once initiated for opioid relapse prevention, according to a study published online Nov. 14 in The Lancet.

Joshua D. Lee, M.D., from the New York University School of Medicine in New York City, and colleagues randomized 570 opioid-dependent adults to XR-NTX (administered as monthly intramuscular injections; 283 patients) or BUP-NX (daily self-administered sublingual film; 287 patients) to examine the differences in opioid relapse-free survival.

A significant induction hurdle was seen for XR-NTX, with fewer participants successfully initiating XR-NTX versus BUP-NX (72.1 versus 94.1 percent). The researchers found that in the intent-to-treat (ITT) population, the 24-week relapse rates were greater for XR-NTX than for BUP-NX (65.4 versus 56.8 percent; hazard ratio, 1.36; 95 percent confidence interval, 1.1 to 1.68); most of the difference was due to early relapse, seen in 88.6 percent of XR-NTX induction failures. Among the treated population, the 24-week relapse rates were similar (52 versus 55.6 percent for XR-NTX and BUP-NX, respectively; hazard ratio, 0.92; 95 percent confidence interval, 0.71 to 1.18). In the ITT population, opioid-negative urine samples and opioid-abstinent days significantly favored BUP-NX, while they slightly favored XR-NTX in the as-treated population.

"In this population it is more difficult to initiate patients to XR-NTX than BUP-NX, and this negatively affected overall relapse," the authors write. "Once initiated, both medications were equally safe and effective relapse prevention. Methods to improve XR-NTX induction are needed."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »